Target intelligence / Profile preview

RNA, U6 small nuclear 1244, pseudogene (RNU6-1244P)

Target: RNU6-1244P
Molecular classification: Other (pseudogene), Noncoding RNA (snRNA pseudogene)

Overview

RNA, U6 small nuclear 1244, pseudogene (RNU6-1244P) is a noncoding RNA gene in humans classified as a pseudogene, meaning it is a non-functional copy of genes coding for U6 small nuclear RNA (snRNA). U6 snRNA is a key component of the spliceosome, but RNU6-1244P itself does not produce a functional RNA and has not been demonstrated to play a direct biological or disease-related role. As with other pseudogenes, there is theoretical potential for regulatory influence by acting as miRNA decoys or through epigenetic effects, but specific functions for RNU6-1244P have not been reported in scientific literature to date. There are no reported drug interactions, biomarker uses, or safety concerns associated with RNU6-1244P. Its designation and molecular family are well-documented and correct, but its biological and medical relevance is minimal.

Other names: RNU6-1244PRNA, U6 small nuclear 1244, pseudogene

Mechanism of action

Not applicable (not a therapeutic target or druggable entity)

Biological functions

Potential regulatory roles via pseudogene mechanisms (e.g., miRNA decoy, RNA–protein interactions, epigenetic modulation), but no direct evidence is published for this specific pseudogene as of now

Disease associations

None demonstrated for RNU6-1244P; in general, some pseudogenes may play roles in cancer, but no literature links RNU6-1244P directly to disease

Safety considerations

None described (no therapeutic interventions or safety issues related to this pseudogene)

Interacting drugs

None known (no drugs reported to interact with RNU6-1244P)

Biomarkers

None established (not used for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1244, pseudogene (RNU6-1244P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1244, pseudogene (RNU6-1244P).

Explore the full profile